Skip to content

Mesa Laboratories MLAB SE — Non-Current Assets

Other geography segments

US
$29.89M+2.4%
Non Us
$1.21M+3.8%

Similar metrics at other companies

Bel Fuse logo
BELFBSK — Non-Current Assets
$6.67M+1.7%
Canopy Growth Corporation logo
CGCDE — Non-Current Assets
$50.41M-5.0%
Pursuit Attractions and Hospitality, Inc. logo
PRSUIS — Non-Current Assets
$60.2M+8.6%
Hexcel logo
HXLES — Non-Current Assets
$45.5M+7.3%
LeMaitre Vascular logo
LMATDE — Non-Current Assets
$2.16M-0.2%
Reservoir Media, Inc. logo
RSVRUS — Non-Current Assets
$418.41K+53.1%

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's se — non-current assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's SE — non-current assets?
Mesa Laboratories (MLAB) reported SE — non-current assets of $10.86M in Q1 2026.
What does SE — non-current assets mean?
This metric represents the total value of long-term assets held by the Sterilization and Disinfection Control segment that are not expected to be converted to cash within one year. It encompasses investments in property, plant, equipment, and intangible assets specifically utilized to support the manufacturing and distribution of biological and chemical indicators. Monitoring this balance provides insight into the capital intensity and long-term infrastructure commitment required to maintain the segment's specialized production capabilities.